Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;13(5):276-83.
doi: 10.1159/000242199. Epub 2009 Sep 23.

Views on personalized medicine: do the attitudes of African American and white prescription drug consumers differ?

M De Marco  1 , S Cykert, N Coad, K Doost, J Schaal, B White, D Young, M R Isler, G Corbie-Smith
Affiliations

Views on personalized medicine: do the attitudes of African American and white prescription drug consumers differ?

M De Marco et al. Public Health Genomics. 2010.

Erratum in

  • Public Health Genomics. 2010;13(6):367. Cykert, S [added]; Coad, N [added]; Doost, K [added]; Schaal, J [added]; White, B [added]; Young, D [added]; Isler, M R [added]; Corbie-Smith, G [added]

Abstract

Aims: Although recent advances in pharmacogenomics are making possible the use of genetic testing to determine the best medication for patients, little is known about how patients view such procedures. The aims for this study that were developed collaboratively as part of a community-academic partnership are: (1) What are the attitudes and perceptions of prescription drug consumers concerning personalized medicine and genetic testing for drug compatibility and how do they differ between African American and white patients? (2) What are the attitudes and perceptions of patients concerning race-based prescribing and how do they differ between African American and white patients?

Methods: We conducted 6 focus groups, 2 with white participants and 4 with African American participants. Focus groups were audio-recorded, transcribed, and analyzed to ascertain common themes.

Results: Our results suggest that personalized medicine and genetic testing, though not well understood by lay persons, were considered positive advances in medicine. However, participants also voiced concerns about these advances that differed by race.

Conclusion: This study points to the need to include perspectives of at-risk communities as we move toward wider use of this technology.

PubMed Disclaimer

References

    1. Smart A, Martin P, Parker M. Tailored medicine: whom will it fit? The ethics of patient and disease stratification. Bioethics. 2004;18:322–342. - PubMed
    1. Secretary's Advisory Committee on Genetics, Health, & Society. Realizing the Potential of Pharmacogenomics Opportunities and Challenges: 2008. Available at http://www4.od.nih.gov/oba/sacghs/reports/SACGHS_PGx_report.pdf, accessed June 30, 2008.
    1. Almarsdottir A, Bjornsdottir I, Traulsen J. A lay prescription for tailor-made drugs – focus group reflections on pharmacogenetics. Health Policy. 2005;71:233–241. - PubMed
    1. Catz DS, Green NS, Tobin JN, Lloyd-Puryear MA, Kyler P, Umemoto A, Cernoch J, Brown R, Wolman F. Attitudes about genetics in underserved, culturally diverse populations. Community Genet. 2005;8:161–172. - PubMed
    1. Condit C, Parrot R, Bates B, Bevan J, Achter P. Exploration of the impact of messages about genes and race on lay attitudes. Clin Genet. 2004;66:402–408. - PubMed

Publication types

Substances